Business Context and Reporting Period
Company: Asbury Automotive Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 14, 2025 (Event Date); Signed February 18, 2025
Context: The Company announced the entry into a definitive agreement to acquire substantially all assets of the Herb Chambers automotive group.
Key Financial Metrics and Transaction Details
This filing details a specific acquisition transaction rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction values include:
- Aggregate Purchase Price: Approximately $1.34 billion.
- Goodwill: $750 million.
- Real Estate and Improvements: Approximately $590 million.
- Inventory and Fixed Assets: Purchase price to be determined at closing (includes new/used vehicles, service loaners, parts, and supplies).
- Additional Costs: Reimbursement for certain dealership construction and development costs incurred prior to closing.
- Earnest Money: $10 million deposited into escrow.
- Termination Fee: Up to $100 million payable by the seller under certain circumstances.
Material Changes and Transaction Scope
The transaction represents a significant expansion of the Company's dealership footprint. The acquired assets include:
- 33 dealerships.
- 52 franchises.
- 3 collision centers.
Exclusions and Contingencies: The Herb Chambers Group will retain ownership of the Mercedes-Benz of Boston dealership ("MB Boston Dealership"). However, the agreement includes a put right obligating Asbury to purchase this dealership within five years of closing, absent specific circumstances.
Closing Conditions
The transaction is not subject to financing conditions but requires:
- Approval from certain automotive manufacturers.
- Governmental clearances, including the expiration of the Hart-Scott-Rodino waiting period.
- Assignment of key leases and contracts.
- No material adverse effect occurring prior to closing.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates a press release (Exhibit 99.1) issued on February 18, 2025, regarding the transaction. No specific financial guidance or outlook for the fiscal year is provided in this text.
Risks and Contingencies:
- Regulatory Risk: Closing is contingent on antitrust clearance and manufacturer approvals.
- Operational Risk: The transaction is subject to the absence of a material adverse effect.
- Future Obligation: The put right for the MB Boston Dealership creates a potential future capital outflow obligation within five years.
Investor Verification Checklist
- Verify the final purchase price for inventory and fixed assets once determined at closing.
- Monitor the status of Hart-Scott-Rodino antitrust clearance and manufacturer approvals.
- Review the full text of the Transaction Agreement (to be filed in the Q1 2025 Form 10-Q) for detailed representations, warranties, and indemnification terms.
- Assess the impact of the $1.34 billion acquisition on the Company's leverage ratios and liquidity position upon closing.
- Track the conditions under which the put right for the MB Boston Dealership may be exercised.